Article Versions Notes

Mallis P, Chatzistamatiou T, Gkatzoflia E, Zdrava H, Sarri E-F, Michalopoulos E, Spyridonidis A, Stavropoulos-Giokas C. The Impact of IFN-γ Licensing on Mesenchymal Stromal Cells’ Mediated Immunoregulation and HLA Class II Expression: Emerging Evidence from In Vitro Results. International Journal of Molecular Sciences. 2025; 26(19):9436. https://doi.org/10.3390/ijms26199436

Mallis, Panagiotis, Theofanis Chatzistamatiou, Evangelia Gkatzoflia, Hava Zdrava, Eirini-Faidra Sarri, Efstathios Michalopoulos, Alexandros Spyridonidis, and Catherine Stavropoulos-Giokas. 2025. "The Impact of IFN-γ Licensing on Mesenchymal Stromal Cells’ Mediated Immunoregulation and HLA Class II Expression: Emerging Evidence from In Vitro Results" International Journal of Molecular Sciences 26, no. 19: 9436. https://doi.org/10.3390/ijms26199436

Mallis, P., Chatzistamatiou, T., Gkatzoflia, E., Zdrava, H., Sarri, E.-F., Michalopoulos, E., Spyridonidis, A., & Stavropoulos-Giokas, C. (2025). The Impact of IFN-γ Licensing on Mesenchymal Stromal Cells’ Mediated Immunoregulation and HLA Class II Expression: Emerging Evidence from In Vitro Results. International Journal of Molecular Sciences, 26(19), 9436. https://doi.org/10.3390/ijms26199436